Cardiovascular disease in diabetes

European Review for Medical and Pharmacological Sciences

Volumn 18, Issue 15, 2014, Pages 2205-2214

  Zhang, P Y ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

Atherosclerosis; Cardiomyopathy; Cardiovascular disease; Coronary artery disease; Diabetes; Heart failure; Heprinsulinemia; Hyperglycemia; Insulin resistance; Obesity

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; GLICLAZIDE; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDAPAMIDE PLUS PERINDOPRIL; INSULIN; METFORMIN;

BODY MASS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL (TOPIC); CONTROLLED CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; DISEASE ASSOCIATION; DISORDERS OF LIPID METABOLISM; GENE EXPRESSION; HEART FUNCTION; HEART MUSCLE; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; MEDLINE; META ANALYSIS (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATIVE STRESS; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; CARDIOVASCULAR DISEASES; COMPLICATION; HEART FAILURE; PHYSIOLOGY;

BODY MASS INDEX; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HEART FAILURE; HUMANS; HYPERGLYCEMIA; INSULIN RESISTANCE; OBESITY; RISK FACTORS;

EID: 84926080135     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Grundy Sm, Benjamin Ij, Burke Gl, Chait A, Eckel Rh, Howard Bv, Mitch W, Smith Sc, Jr., Sowers Jr. Diabetes And Cardiovascular Disease: A Statement For Healthcare Professionals From The American Heart Association. Circulation 1999; 100: 1134-1146.
2. Gray Sp, Jandeleit-Dahm K. The Pathobiology Of Diabetic Vascular Complications-Cardiovascular And Kidney Disease. J Mol Med (Berl) 2014; 92: 441-452.
3. Cleland Sj. Cardiovascular Risk In Double Diabetes Mellitus-When Two Worlds Collide. Nat Rev Endocrinol 2012; 8: 476-485.
4. Aneja A, Tang Wh, Bansilal S, Garcia Mj, Farkouh Me. Diabetic Cardiomyopathy: Insights Into Pathogenesis, Diagnostic Challenges, And Therapeutic Options. Am J Med. 2008; 121: 748-757.
5. Cohn Jn, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, Smith R, Dunkman Wb, Loeb H, Wong M, Bhat G, Goldman S, Fletcher Rd, Doherty J, Hughes Cv, Carson P, Cintron G, Shabetai R, Haakenson C. A Comparison Of Enalapril With Hydralazineisosorbide Dinitrate In The Treatment Of Chronic Congestive Heart Failure. N Engl J Med 1991; 325: 303-310.
6. Ryden L, Armstrong Pw, Cleland Jg, Horowitz Jd, Massie Bm, Packer M, Poole-Wilson Pa. Efficacy And Safety Of High-Dose Lisinopril In Chronic Heart Failure Patients At High Cardiovascular Risk, Including Those With Diabetes Mellitus. Results From The Atlas Trial. Eur Heart J 2000; 21: 1967-1978.
7. Shindler Dm, Kostis Jb, Yusuf S, Quinones Ma, Pitt B, Stewart D, Pinkett T, Ghali Jk, Wilson Ac. Diabetes Mellitus, A Predictor Of Morbidity And Mortality In The Studies Of Left Ventricular Dysfunction (Solvd) Trials And Registry. Am J Cardiol 1996; 77: 1017-1020.
8. Fang Zy, Prins Jb, Marwick Th. Diabetic Cardiomyopathy: Evidence, Mechanisms, And Therapeutic Implications. Endocr Rev 2004; 25: 543-567.
9. Ma Rc, Chan Jc. Type 2 Diabetes In East Asians: Similarities And Differences With Populations In Europe And The United States. Ann N Y Acad Sci 2013; 1281: 64-91.
10. Aragno M, Mastrocola R, Medana C, Catalano Mg, Vercellinatto I, Danni O, Boccuzzi G. Oxidative Stress-Dependent Impairment Of Cardiac-Specific Transcription Factors In Experimental Diabetes. Endocrinology 2006; 147: 5967-5974.
11. Du X, Matsumura T, Edelstein D, Rossetti L, Zsengeller Z, Szabo C, Brownlee M. Inhibition Of Gapdh Activity By Poly(Adp-Ribose) Polymerase Activates Three Major Pathways Of Hyperglycemic Damage In Endothelial Cells. J Clin Invest 2003; 112: 1049-1057.
12. Petrova R, Yamamoto Y, Muraki K, Yonekura H, Sakurai S, Watanabe T, Li H, Takeuchi M, Makita Z, Kato I, Takasawa S, Okamoto H, Imaizumi Y, Yamamoto H. Advanced Glycation Endproduct-Induced Calcium Handling Impairment In Mouse Cardiac Myocytes. J Mol Cell Cardiol 2002; 34: 1425-1431.
13. Gawlowski T, Stratmann B, Stork I, Engelbrecht B, Brodehl A, Niehaus K, Korfer R, Tschoepe D, Milting H. Heat Shock Protein 27 Modification Is Increased In The Human Diabetic Failing Heart. Horm Metab Res 2009; 41: 594-599.
14. Burgess Ml, Mccrea Jc, Hedrick Hl. Age-Associated Changes In Cardiac Matrix And Integrins. Mech Ageing Dev 2001; 122: 1739-1756.
15. Mariappan N, Elks Cm, Sriramula S,F.
16. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven Pd, Zieve Fj, Marks J, Davis Sn, Hayward R, Warren Sr, Goldman S, Mccarren M, Vitek Me, Henderson Wg, Huang Gd. Glucose Control And Vascular Complications In Veterans With Type 2 Diabetes. N Engl J Med 2009; 360: 129-139.
17. Holman Rr, Paul Sk, Bethel Ma, Matthews Dr, Neil Ha. 10-Year Follow-Up Of Intensive Glucose Control In Type 2 Diabetes. N Engl J Med 2008; 359: 1577-1589.
18. Rijzewijk Lj, Van Der Meer Rw, Smit Jw, Diamant M, Bax Jj, Hammer S, Romijn Ja, De Roos A, Lamb Hj. Myocardial Steatosis Is An Independent Predictor Of Diastolic Dysfunction In Type 2 Diabetes Mellitus. J Am Coll Cardiol 2008; 52: 1793-1799.
19. Winhofer Y, Krssak M, Jankovic D, Anderwald Ch, Reiter G, Hofer A, Trattnig S, Luger A, Krebs M. Short-Term Hyperinsulinemia And Hyperglycemia Increase Myocardial Lipid Content In Normal Subjects. Diabetes 2012; 61: 1210-1216.
20. Iozzo P, Lautamaki R, Borra R, Lehto Hr, Bucci M, Viljanen A, Parkka J, Lepomaki V, Maggio R, Parkkola R, Knuuti J, Nuutila P. Contribution Of Glucose Tolerance And Gender To Cardiac Adiposity. J Clin Endocrinol Metab 2009; 94: 4472-4482.
21. Mcgavock Jm, Lingvay I, Zib I, Tillery T, Salas N, Unger R, Levine Bd, Raskin P, Victor Rg, Szczepaniak Ls. Cardiac Steatosis In Diabetes Mellitus: A 1Hmagnetic Resonance Spectroscopy Study. Circulation 2007; 116: 1170-1175.
22. Unger Rh. Lipotoxic Diseases. Annu Rev Med 2002; 53: 319-336.
23. Van De Wei Jer T, Schrauwen-Hinderling Vb, Schrauwen P. Lipotoxicity In Type 2 Diabetic Cardiomyopathy. Cardiovasc Res 2011; 92: 10-18.
24. Balaban Rs. Cardiac Energy Metabolism Homeostasis: Role Of Cytosolic Calcium. J Mol Cell Cardiol 2002; 34: 1259-1271.
25. Perseghin G, Lattuada G, De Cobelli F, Esposito A, Costantino F, Canu T, Scifo P, De Taddeo F, Maffi P, Secchi A, Del Maschio A, Luzi L. Reduced Intrahepatic Fat Content Is Associated With Increased Whole-Body Lipid Oxidation In Patients With Type 1 Diabetes. Diabetologia 2005; 48: 2615-2621.
26. Heptulla Ra, Stewart A, Enocksson S, Rife F, Ma Ty, Sherwin Rs, Tamborlane Wv, Caprio S. In Situ Evidence That Peripheral Insulin Resistance In Adolescents With Poorly Controlled Type 1 Diabetes Is Associated With Impaired Suppression Of Lipolysis: A Microdialysis Study. Pediatr Res 2003; 53: 830-835.
27. Prince Ct, Becker Dj, Costacou T, Miller Rg, Orchard Tj. Changes In Glycaemic Control And Risk Of Coronary Artery Disease In Type 1 Diabetes Mel-Litus: Findings From The Pittsburgh Epidemiology Of Diabetes Complications Study (Edc). Diabetologia 2007; 50: 2280-2288.
28. Gale Ea. How To Survive Diabetes. Diabetologia 2009; 52: 559-567.
29. Betteridge Dj. Lipid Control In Patients With Diabetes Mellitus. Nat Rev Cardiol 2011; 8: 278-290.
30. Ruotolo G, Parlavecchia M, Taskinen Mr, Galimberti G, Zoppo A, Le Na, Ragogna F, Micossi P, Pozza G. Normalization Of Lipoprotein Composition By Intraperitoneal Insulin In Iddm. Role Of Increased Hepatic Lipase Activity. Diabetes Care 1994; 17: 6-12.
31. Petruzzo P, Badet L, Lefrancois N, Berthillot C, Dorel Sb, Martin X, Laville M. Metabolic Consequences Of Pancreatic Systemic Or Portal Venous Drainage In Simultaneous Pancreas-Kidney Transplant Recipients. Diabet Med 2006; 23: 654-659.
32. Mayer-Davis Ej, Ma B, Lawson A, D'agostino Rb, Jr., Liese Ad, Bell Ra, Dabelea D, Dolan L, Pettitt Dj, Rodriguez Bl, Williams D. Cardiovascular Disease Risk Factors In Youth With Type 1 And Type 2 Diabetes: Implications Of A Factor Analysis Of Clustering. Metab Syndr Relat Disord 2009; 7: 89-95.
33. Lehto S, Ronnemaa T, Haffner Sm, Pyorala K, Kallio V, Laakso M. Dyslipidemia And Hyperglycemia Predict Coronary Heart Disease Events In Middleaged Patients With Niddm. Diabetes 1997; 46: 1354-1359.
34. Deloukas P, Kanoni S, Willenborg C, Farrall M, Assimes Tl, Thompson Jr, Ingelsson E, Saleheen D, Erdmann J, Goldstein Ba, Stirrups K, Konig Ir, Cazier Jb, Johansson A, Hall As, Lee Jy, Willer Cj, Chambers Jc, Esko T, Folkersen L, Goel A, Grundberg E, Havulinna As, Ho Wk, Hopewell Jc, Eriksson N, Kleber Me, Kristiansson K, Lundmark P, Lyytikainen Lp, Rafelt S, Shungin D, Strawbridge Rj, Thorleifsson G, Tikkanen E, Van Zuydam N, Voight Bf, Waite Ll, Zhang W, Ziegler A, Absher D, Altshuler D, Balmforth Aj, Barroso I, Braund Ps, Burgdorf C, Claudi-Boehm S, Cox D, Dimitriou M, Do R, Doney As, El Mokhtari N, Eriksson P, Fischer K, Fontanillas P, Franco-Cereceda A, Gigante B, Groop L, Gustafsson S, Hager J, Hallmans G, Han Bg, Hunt Se, Kang Hm, Illig T, Kessler T, Knowles Jw, Kolovou G, Kuusisto J, Langenberg C, Langford C, Leander K, Lokki Ml, Lundmark A, Mccarthy Mi, Meisinger C, Melander O, Mihailov E, Maouche S, Morris Ad, Muller-Nurasyid M, Nikus K, Peden Jf, Rayner Nw, Rasheed A, Rosinger S, Rubin D, Rumpf Mp, Schafer A, Sivananthan M, Song C, Stewart Af, Tan St, Thorgeirsson G, Van Der Schoot Ce, Wagner Pj, Wells Ga, Wild Ps, Yang Tp, Amouyel P, Arveiler D, Basart H, Boehnke M, Boerwinkle E, Brambilla P, Cambien F, Cupples Al, De Faire U, Dehghan A, Diemert P, Epstein Se, Evans A, Ferrario Mm, Ferrieres J, Gauguier D, Go As, Goodall Ah, Gudnason V, Hazen Sl, Holm H, Iribarren C, Jang Y, Kahonen M, Kee F, Kim Hs, Klopp N, Koenig W, Kratzer W, Kuulasmaa K, Laakso M, Laaksonen R, Lee Jy, Lind L, Ouwehand Wh, Parish S, Park Je, Pedersen Nl, Peters A, Quertermous T, Rader Dj, Salomaa V, Schadt E, Shah Sh, Sinisalo J, Stark K, Stefansson K, Tregouet Da, Virtamo J, Wallentin L, Wareham N, Zimmermann Me, Nieminen Ms, Hengstenberg C, Sandhu Ms, Pastinen T, Syvanen Ac, Hovingh Gk, Dedoussis G, Franks Pw, Lehtimaki T, Metspalu A, Zalloua Pa, Siegbahn A, Schreiber S, Ripatti S, Blankenberg Ss, Perola M, Clarke R, Boehm Bo, O'donnell C, Reilly Mp, Marz W, Collins R, Kathiresan S, Hamsten A, Kooner Js, Thorsteinsdottir U, Danesh J, Palmer Cn, Roberts R, Watkins H, Schunkert H, Samani Nj. Large-Scale Association Analysis Identifies New Risk Loci For Coronary Artery Disease. Nat Genet 2013; 45: 25-33.
35. Hummasti S, Hotamisligil Gs. Endoplasmic Reticulum Stress And Inflammation In Obesity And Diabetes. Circ Res 2010; 107: 579-591.
36. Kanter Je, Kramer F, Barnhart S, Averill Mm, Vivekanandan-Giri A, Vickery T, Li Lo, Becker L, Yuan W, Chait A, Braun Kr, Potter-Perigo S, Sanda S, Wight Tn, Pennathur S, Serhan Cn, Heinecke Jw, Coleman Ra, Bornfeldt Ke. Diabetes Promotes An Inflammatory Macrophage Phenotype And Atherosclerosis Through Acyl-Coa Synthetase 1. Proc Natl Acad Sci U S A 2012; 109: E715-724.
37. Cersosimo E, Defronzo Ra. Insulin Resistance And Endothelial Dysfunction: The Road Map To Cardiovascular Diseases. Diabetes Metab Res Rev 2006; 22: 423-436.
38. Nunes S, Soares E, Fernandes J, Viana S, Carvalho E, Pereira Fc, Reis F. Early Cardiac Changes In A Rat Model Of Prediabetes: Brain Natriuretic Peptide Overexpression Seems To Be The Best Marker. Cardiovasc Diabetol 2013; 12: 44.
39. Feng B, Chen S, Chiu J, George B, Chakrabarti S. Regulation Of Cardiomyocyte Hypertrophy In Diabetes At The Transcriptional Level. Am J Physiol Endocrinol Metab 2008; 294: E1119-1126.
40. Kaur H, Chen S, Xin X, Chiu J, Khan Za, Chakrabarti S. Diabetes-Induced Extracellular Matrix Protein Expression Is Mediated By Transcription Coactivator P300. Diabetes 2006; 55: 3104-3111.
41. Schauer Ie, Snell-Bergeon Jk, Bergman Bc, Maahs Dm, Kretowski A, Eckel Rh, Rewers M. Insulin Resistance, Defective Insulin-Mediated Fatty Acid Suppression, And Coronary Artery Calcification In Subjects With And Without Type 1 Diabetes: The Cacti Study. Diabetes 2011; 60: 306-314.
42. Williams Kv, Erbey Jr, Becker D, Arslanian S, Orchard Tj. Can Clinical Factors Estimate Insulin Resistance In Type 1 Diabetes? Diabetes 2000; 49: 626-632.
43. Chaturvedi N, Sjoelie Ak, Porta M, Aldington Sj, Fuller Jh, Songini M, Kohner Em. Markers Of Insulin Resistance Are Strong R Isk Factors For Retinopathy Incidence In Type 1 Diabetes. Diabetes Care 2001; 24: 284-289.
44. Yki-Jarvinen H, Taskinen Mr, Kiviluoto T, Hilden H, Helve E, Koivisto Va, Nikkila Ea. Site Of Insulin Resistance In Type 1 Diabetes: Insulin-Mediated Glucose Disposal In Vivo In Relation To Insulin Binding And Action In Adipocytes In Vitro. J Clin Endocrinol Metab 1984; 59: 1183-1192.
45. Kahn Bb, Rosen As, Bak Jf, Andersen Ph, Damsbo P, Lund S, Pedersen O. Expression Of Glut1 And Glut4 Glucose Transporters In Skeletal Muscle Of Humans With Insulin-Dependent Diabetes Mellitus: Regulatory Effects Of Metabolic Factors. J Clin Endocrinol Metab 1992; 74: 1101-110.9
46. Baron Ad. Cardiovascular Actions Of Insulin In Humans. Implications For Insulin Sensitivity And Vascular Tone. Baillieres Clin Endocrinol Metab 1993; 7: 961-987.
47. Gast Kb, Tjeerdema N, Stijnen T, Smit Jw, Dekkers Om. Insulin Resistance And Risk Of Incident Cardiovascular Events In Adults Without Diabetes: Metaanalysis. Plos One 2012; 7: E52036.
48. Alberti Kg, Eckel Rh, Grundy Sm, Zimmet Pz, Cleeman Ji, Donato Ka, Fruchart Jc, James Wp, Loria Cm, Smith Sc, Jr. Harmonizing The Metabolic Syndrome: A Joint Interim Statement Of The International Diabetes Federation Task Force On Epidemiology And Prevention; National Heart, Lung, And Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; And International Association For The Study Of Obesity. Circulation 2009; 120: 1640-1645.
49. Bornfeldt Ke, Tabas I. Insulin Resistance, Hyperglycemia, And Atherosclerosis. Cell Metab 2011; 14: 575-585.
50. Chiu Kc, Cohan P, Lee Np, Chuang Lm. Insulin Sensitivity Differs Among Ethnic Groups With A Compensatory Response In Beta-Cell Function. Diabetes Care 2000; 23: 1353-1358.
51. Gujral Up, Pradeepa R, Weber Mb, Narayan Km, Mohan V. Type 2 Diabetes In South Asians: Similarities And Differences With White Caucasian And Other Populations. Ann N Y Acad Sci 2013; 1281: 51-63
52. Han S, Liang Cp, Devries-Seimon T, Ranalletta M, Welch Cl, Collins-Fletcher K, Accili D, Tabas I, Tall Ar. Macrophage Insulin Receptor Deficiency Increases Er Stress-Induced Apoptosis And Necrotic Core Formation In Advanced Atherosclerotic Lesions. Cell Metab 2006; 3: 257-266.
53. Whitfield Jb. Genetic Insights Into Cardiometabolic Risk Factors. Clin Biochem Rev. 2014; 35: 15-36.
54. Benn M, Tybjaerg-Hansen A, Mccarthy Mi, Jensen Gb, Grande P, Nordestgaard Bg. Nonfasting Glucose, Ischemic Heart Disease, And Myocardial Infarction: A Mendelian Randomization Study. J Am Coll Cardiol 2012; 59: 2356-2365.
55. Haddad Jj. Science Review: Redox And Oxygensensitive Transcription Factors In The Regulation Of Oxidant-Mediated Lung Injury: Role For Nuclear Factor-Kappab. Crit Care 2002; 6: 481-490.
56. Brasacchio D, Okabe J, Tikellis C, Balcerczyk A, George P, Baker Ek, Calkin Ac, Brownlee M, Cooper Me, El-Osta A. Hyperglycemia Induces A Dynamic Cooperativity Of Histone Methylase And Demethylase Enzymes Associated With Gene-Activating Epigenetic Marks That Coexist On The Lysine Tail. Diabetes 2009; 58: 1229-1236.
57. Pappachan Jm, Varughese Gi, Sriraman R, Arunagirinathan G. Diabetic Cardiomyopathy: Pathophysiology, Diagnostic Evaluation And Management. World J Diabetes 2013; 4: 177-189.
58. Kodama S, Tanaka S, Heianza Y, Fuj Ihara K, Horikawa C, Shimano H, Saito K, Yamada N, Ohashi Y, Sone H. Association Between Physical Activity And Risk Of All-Cause Mortality And Cardiovascular Disease In Patients With Diabetes: A Meta-Analysis. Diabetes Care 2013; 36: 471-479.
59. Aboukhoudir F, Rekik S. Left Ventricular Systolic Function Deterioration During Dobutamine Stress Echocardiography As An Early Manifestation Of Diabetic Cardiomyopathy And Reversal By Optimized Therapeutic Approach. Int J Cardiovasc Imaging 2012; 28: 1329-1339
60. Xie Z, Lau K, Eby B, Lozano P, He C, Pennington B, Li H, Rathi S, Dong Y, Tian R, Kem D, Zou Mh. Improvement Of Cardiac Functions By Chronic Metformin Treatment Is Associated With Enhanced Cardiac Autophagy In Diabetic Ove26 Mice. Diabetes 2011; 60: 1770-1778.
61. Chen Yh, Feng B, Chen Zw. Statins For Primary Prevention Of Cardiovascular And Cerebrovascular Events In Diabetic Patients Without Established Cardiovascular Diseases: A Meta-Analysis. Exp Clin Endocrinol Diabetes 2012; 120: 116-120.
62. Hoy Aj, Brandon Ae, Turner N, Watt Mj, Bruce Cr, Cooney Gj, Kraegen Ew. Lipid And Insulin Infusion-Induced Skeletal Muscle Insulin Resistance Is Likely Due To Metabolic Feedback And Not Changes In Irs-1, Akt, Or As 160 Phosphorylation. Am J Physiol Endocrinol Metab 2009; 297: E67-75.
63. Hoehn Kl, Salmon Ab, Hohnen-Behrens C, Turner N, Hoy Aj, Maghzal Gj, Stocker R, Van Remmen H, Kraegen Ew, Cooney Gj, Richardson Ar, James De. Insulin Resistance Is A Cellular Antioxidant Defense Mechanism. Proc Natl Acad Sci U S A 2009; 106: 17787-17792.
64. Bonnard C, Durand A, Peyrol S, Chanseaume E, Chauvin Ma, Morio B, Vidal H, Rieusset J. Mitochondrial Dysfunction Results From Oxidative Stress In The Skeletal Muscle Of Diet-Induced Insulin-Resistant Mice. J Clin Invest 2008; 118: 789-800.
65. Purnell Jq, Hokanson Je, Marcovina Sm, Steffes Mw, Cleary Pa, Brunzell Jd. Effect Of Excessive Weight Gain With Intensive Therapy Of Type 1 Diabetes On Lipid Levels And Blood Pressure: Results From The Dcct. Diabetes Control And Complications Trial. Jama 1998; 280: 140-146.